Frequency, predictors, and consequences of crossing over to revascularization within 12 months of randomization to optimal medical therapy in the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial
about
Frequency, predictors, and consequences of crossing over to revascularization within 12 months of randomization to optimal medical therapy in the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Frequency, predictors, and con ...... rug Evaluation (COURAGE) trial
@en
Frequency, predictors, and con ...... ug Evaluation (COURAGE) trial.
@nl
type
label
Frequency, predictors, and con ...... rug Evaluation (COURAGE) trial
@en
Frequency, predictors, and con ...... ug Evaluation (COURAGE) trial.
@nl
prefLabel
Frequency, predictors, and con ...... rug Evaluation (COURAGE) trial
@en
Frequency, predictors, and con ...... ug Evaluation (COURAGE) trial.
@nl
P2093
P2860
P1476
Frequency, predictors, and con ...... rug Evaluation (COURAGE) trial
@en
P2093
Clinical Outcomes Utilizing Re ...... Investigators and Coordinators
Daniel S Berman
David J Cohen
David J Maron
G B John Mancini
John A Spertus
Leslee J Shaw
Marcin Dada
Merril Knudtson
Mihaela Aslan
P2860
P304
P356
10.1161/CIRCOUTCOMES.113.000139
P577
2013-07-09T00:00:00Z